Evidence Files

Vitamin D: The Supplement Everyone Takes and the Evidence Nobody Talks About

VITAL followed 25,871 adults for a median of 5.3 years. Vitamin D supplements did not reduce cancer. They did not reduce cardiovascular events. And in the fracture analysis — the outcome most people take vitamin D for — the hazard ratio was 0.98, with p = 0.70. Correcting a genuine deficiency remains worth doing. Taking vitamin D because everyone does is a different proposition, and this is the trial that tested it.

Published: 20 June 2026

Verdict

TREATMENT (partially confirmed)

We searched PubMed and Cochrane Library for vitamin D evidence. One direction is clear and unchanged: correcting genuine deficiency prevents rickets and osteomalacia, and that is not in dispute. The other direction is where the last decade rewrote expectations. VITAL, with 25,871 participants, found no reduction in invasive cancer or cardiovascular events versus placebo. Its fracture analysis found no significant effect on total fractures (HR 0.98, p = 0.70), non-vertebral fractures or hip fractures — and no subgroup did better, including people with lower baseline vitamin D levels.

Why supplementation became the default

Vitamin D deficiency is genuinely common in Northern Europe — shorter days, indoor lifestyles, and sun-protective behaviour mean many people don't synthesise enough through skin exposure. Observational studies showed that low vitamin D levels correlated with higher rates of cancer, cardiovascular disease, diabetes, and depression. The logical leap: supplement it and those rates will fall.

That leap turned out to be more complicated than it looked. Correlation in observational studies doesn't reliably translate to causation in randomised trials. Low vitamin D might be a marker of poor health rather than its cause — sick people go outside less, eat less diversely, and have lower vitamin D as a result.

The large RCTs that followed — VITAL, D-HEALTH, FIND, ViDA — tested supplementation in people with normal or near-normal levels. The results were largely disappointing for the headline claims.

Where the evidence is strong vs. where it falls short

VITAL is the trial that settles most of this, because it was large, long, independent, and designed to answer exactly these questions.

Deficiency correction: not in question. Vitamin D prevents rickets in children and osteomalacia in adults. Nothing below changes that, and it is the reason vitamin D is a medicine rather than a wellness product
Cancer: no. VITAL, 25,871 participants over a median 5.3 years, found no lower incidence of invasive cancer than placebo
Cardiovascular disease: no. The same trial found no reduction in major cardiovascular events
Fractures: no — and this is the surprising one. The VITAL fracture analysis found a hazard ratio of 0.98 (p = 0.70) for total fractures, 0.97 for non-vertebral and 1.01 for hip fractures. Bone health is the single most common reason people take vitamin D
No subgroup did better, including people with lower vitamin D levels. The authors specifically checked whether the effect differed by age, sex, body-mass index or baseline 25-hydroxyvitamin D, and found no modification. That is the finding that undercuts the usual rescue argument — *it must work in the people who need it*
The population matters. VITAL enrolled generally healthy adults not selected for deficiency, low bone mass or osteoporosis. It answers "should the average person supplement", not "should a deficient patient be treated" — and those remain different questions

What the supplement industry claims vs. what the evidence shows

Common marketing claims

"Supports immune health, bone health, mood, and energy." "Essential for Northern European winters." "Most people are deficient." Often sold at doses of 1,000-4,000 IU/day for general wellness.

What the evidence shows

Correcting genuine deficiency: supported, and that is real medicine. Everything else sold on the label — cancer prevention, cardiovascular protection, and even fracture prevention — was tested in 25,871 people and did not hold up. Find out whether you are deficient rather than assuming it.

Frequently asked questions

Does vitamin D protect my bones?

If you are deficient, treating that deficiency protects your bones — that much is settled. If you are not, the honest answer changed in 2022. The VITAL fracture analysis followed 25,871 generally healthy adults and found no significant reduction in total fractures (HR 0.98, p = 0.70), non-vertebral fractures or hip fractures. Bone protection is the most common reason people take vitamin D, and it is the claim this trial specifically failed to confirm.

But surely it works in people with low levels?

That is the obvious objection, and the trial authors tested it directly. They looked for modification of the treatment effect by baseline 25-hydroxyvitamin D, age, sex, race and body-mass index, and found none. It's worth being precise about what this does and doesn't mean: VITAL enrolled people not selected for deficiency, so it doesn't speak to treating a diagnosed deficiency. It does undercut the idea that supplementing the merely lower-than-average brings benefit.

Should I get tested?

Testing makes sense when there's a reason to suspect deficiency — very little sun exposure, darker skin at northern latitudes, malabsorption, certain medications, osteoporosis, or symptoms suggesting it. Routine screening of healthy people isn't recommended in most guidelines, largely because the treatment it leads to hasn't shown benefit in that group. Which is the same conclusion arrived at from the other direction.

What about vitamin D and COVID-19 or immunity generally?

The immunity claims ran far ahead of the trials, and the trials have mostly not caught up. VITAL, the largest dataset available, found no reduction in cancer or cardiovascular events; it was not designed as an infection trial, but the broader pattern across large vitamin D trials has been consistent disappointment relative to the observational signals that inspired them.

Why did observational studies look so promising?

Because low vitamin D is an excellent marker of poor health without necessarily being its cause. People who are ill, frail, housebound or eating badly go outside less and have lower vitamin D as a consequence. Observational data cannot separate the marker from the mechanism — which is exactly what a randomised trial is for, and why VITAL's answer differs so sharply from the correlations that preceded it.

Our Conclusion

Vitamin D is real medicine for people who actually lack it, and nothing here changes that. What did change is the case for everyone else. VITAL tested it properly — 25,871 adults, more than five years — and found no reduction in cancer, none in cardiovascular events, and none in fractures, which is the reason most people take it in the first place. The authors went looking for the subgroup where it would work, including people with lower baseline levels, and didn't find one. The practical version is short: find out whether you're deficient instead of assuming it. If you are, treat it with guidance on dose. If you aren't, the evidence doesn't support taking it to prevent disease — and sunlight is still free.

Sources

Every claim in this article rests on a primary publication. Links go to the publisher's site or to PubMed, the US National Library of Medicine database.

This article is for informational purposes only and does not constitute medical advice. Trick or Treatment analyses the presence of clinical studies in open scientific databases — PubMed and Cochrane Library. The absence of studies in these databases does not automatically mean a drug is ineffective, but it does mean its effectiveness has not been confirmed by evidence-based medicine standards. Any treatment decisions should be made together with your doctor.